Business ❯Corporate News
Market Trends Earnings Reports Pharmaceutical Companies Healthcare Sector Qualcomm Company Announcements Sector Analysis Company Investments Company Shares Technology Sector Key Companies Company Earnings Market Reactions Technology Stocks Market Analysis
AbbVie's emraclidine failed to meet key endpoints in Phase 2 trials, impacting its $8.7 billion acquisition of Cerevel Therapeutics.
